@snailjump5
Active 16 hours, 54 minutes ago
Receptor tyrosine kinase inhibitors have become a central part of modern targeted cancer therapy. However, their curative potential is distinctly limited by both rapid resistance development and severe adverse effects. Consequently, tumor-specific drug activation based on prodrug designs, exploiting tumor-specific properties such as hypoxic […] View
Sorry, there was no activity found. Please try a different filter.
